Abstract

Purified human plasma fibronectin has been shown to agglutinate protease-treated red cells [Vuento, Hoppe-Seyler's Z. Physiol. Chem. 360, 1327-1333, (1979)]. The present report shows that the activity is inhibited by low concentrations of lectins and by macromolecular serum factors. Chemical modification of carboxyl groups of fibronectin strongly inhibited the activity, but modification of amino groups of guanidinium groups had little effect on the activity. The results suggest that fibronectin receptors on erythrocyte surface are carbohydrate-containing molecules. Humoral macromolecular factors may control the interaction of fibronectin with cell surfaces. Chemical modification studies indicate that the parts of the fibronectin molecule responsible for the hemagglutinin activity are different from those mediating the binding of fibronectin to collagen.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.